Tilray | TRLY - Market Capitalization

Stock Price
10.43
Daily Change
-0.18 -1.70%
Monthly
-20.32%
Yearly
577.27%
Q1 Forecast
9.94

Tilray reported $8.04B in Market Capitalization this February of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Alaunos Therapeutics USD 5M 2M Sep/2025
Aurora Cannabis CAD 470.14M 146.16M Sep/2025
Avita Medical AUD 140.79M 194.8M Jun/2025
Canopy Growth CAD 136.67M 644.68M Feb/2026
Cronos Group USD 1.06B 319.22M Sep/2025
Dianthus Therapeutics USD 1.57B 1000K Feb/2026
Divis Laboratories Ltd INR 1.51T 297.32B Sep/2025
Ionis Pharmaceuticals USD 10.43B 4.14B Sep/2025
IQVIA Holdings USD 32.29B 5.03B Sep/2025
Knight Therapeutics CAD 580.82M 31.21M Jun/2025
Moderna USD 10.09B 581M Sep/2025
Organigram Holdings CAD 191.77M 187.03M Feb/2026
Organon & Co USD 2.18B 593.28M Feb/2026
Revvity USD 13.23B 3.47B Feb/2026
Tectonic Therapeutic USD 294M 77M Sep/2025
Viatris USD 11.54B 1.06B Sep/2025
Xeris Pharmaceuticals USD 1.03B 281M Feb/2026